Sheesh I missed all the fun today. I agree with Frrol on

New Post Public Reply Private Reply Replies (2) Message Board
Haschwald_Zimmer
252
Sheesh I missed all the fun today.

I agree with Frrol on the other site that CTIX does not have the identity of Mako. If Cellceutix knew who Mako was and had provable damages they would have initiated a suit. There are two roadblocks for a civil suit in this case:

1. The identity of Mako needs to be discovered.
If CTIX knows the identity this is not a road block. The problem here is that Mako's work is formulaic just like Pump Stopper/Terminator (we all think they one and the same). NNVC attempted to get Seeking Alpha to disclose the identity of Mako and the case was thrown out. The same would likely happen against Mako which is why no civil discover was ever attempted. For the same reason I believe it will not be attempted in this case.

2. Cellceutix must prove damages.
A civil libel suit requires damages. Market cap changes alone are not damages and assigning blame for them is very difficult. If we recover to yesterdays price tomorrow I don't think they could plead for damages.

A criminal case is a different story. Damages would not need to be proven by the SEC only that an article with untrue facts was written with the intent tank the stock. The opinion defense would still be a substantial road block (if it prevents discovery it could cause charges to be thrown out) but would not be a sure thing. The criminal case could go either way. Any evidence of conspiracy to commit securities fraud would work against Mako.

In summary, I think that both Mako articles are complete BS with the intent to defraud. Unfortunately I believe they have been carefully crafted in order to hide behind the precedent set in the NNVC vs Seeking Alpha case in order to block discovery and defend against securities fraud charges. I believe only solid evidence of conspiracy to commit securities fraud, if it exists, would be enough to have the SEC go after Mako.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.

Current Positions:
Long CTIX.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

IntelAgree Recognized for Advanced AI Solutions in CLM

Updated Category News Views 283

IntelAgree Recognized for Innovation in CLM IntelAgree, a leading player in contract lifecycle management (CLM) powered by artificial intelligence, has recently been honored as an 'Advanced Solution' in a distinguished analysis by The Hackett Group. This recognition solidifies IntelAgree’s reputation as a top platform in the business sector. Importance of The Hackett...

Continue Reading
Emergency Health Workers in South Dakota Unionize with Teamsters

Updated Category News Views 248

Emergency Health Professionals Unite with Teamsters Local 120 Recently, a remarkable development unfolded as a dedicated group of 15 paramedics, EMTs, and emergency health professionals came together to join Teamsters Local 120. This resolute decision signifies their commitment to securing better working conditions and fair compensation. The Journey Toward Unionization...

Continue Reading
MSI Showcases Innovative Cloud Solutions at CloudFest 2025

Updated Category News Views 324

MSI Unveils Future-Proof Cloud Solutions At CloudFest 2025, MSI, a leader in high-performance server solutions, introduced its innovative next-generation server platforms, including the ORv3 Servers, DC-MHS Servers, and NVIDIA MGX™ AI Servers. This significant event showcased MSI's commitment to enhancing cloud infrastructure with a focus on scalability, performance,...

Continue Reading
St. Cloud Capital Invests in Mobile Diagnostic Services Expansion

Updated Category News Views 110

St. Cloud Capital's Growth Capital Investment St. Cloud Capital has proudly announced a significant investment in Integrated Diagnostic Services (IDS). This initiative focuses on expanding their capabilities in mobile radiology and laboratory services. The investment aims to support IDS in acquiring Core Analytics Lab & Radiology, a leading provider in California....

Continue Reading
LeMaitre Vascular's Impressive Q3 2024 Performance Report

Updated Category News Views 83

LeMaitre Vascular Shows Robust Growth in Q3 2024 BURLINGTON, Mass. – LeMaitre Vascular, Inc. (NASDAQ: LMAT), a leading provider of vascular devices and services, has reported exceptional results for the third quarter of 2024. The company’s strong performance demonstrates its commitment to innovation in the medical device sector, especially in the area of vascular...

Continue Reading